Ultrasound-enhanced transfection activity of HPMA-stabilized DNA polyplexes with prolonged plasma circulation.
Cancer gene therapy would greatly benefit from the possibility to deliver therapeutic genes via tumor-targeted systemic intravenous delivery. The main objective of this study was to determine biophysical, transfection, and pharmacokinetic properties of DNA complexes with reducible polycations that are reversibly stabilized by surface coating with multivalent HPMA copolymers. The specific goals were to evaluate compatibility of these polyplexes with extended plasma circulation, molecular targeting, and ultrasound-enhanced transfection activity. It was demonstrated that using polyplexes based on reducible polycations allows increasing transfection activity and preserving extended plasma circulation half-life observed for control polyplexes based on non-reducible polycations. In addition, the reversibly stabilized polyplexes were compatible with both molecular targeting using protein ligands as well as physical targeting using ultrasound-directed cavitation in vitro. As such, the described gene delivery vectors have the potential to permit efficient systemic delivery of therapeutic genes targeted by a local focused ultrasound treatment.
Zhou
Qing-Hui
QH
Department of Pharmaceutical Sciences, Wayne State University, Detroit, MI 48202, USA.
Miller
Douglas L
DL
Carlisle
Robert C
RC
Seymour
Leonard W
LW
Oupicky
David
D
D000818:Animals; D004247:DNA / Q000008:administration & dosage* / Q000097:blood; D004355:Drug Stability; D005260:Female; D008689:Methacrylates / Q000008:administration & dosage*; D051379:Mice; D008807:Mice, Inbred BALB C; D011094:Polyethyleneimine / Q000008:administration & dosage; D011107:Polylysine / Q000008:administration & dosage*; D051381:Rats; D014162:Transfection / Q000379:methods*; D014465:Ultrasonics
D008689:Methacrylates; D011107:Polylysine; D011094:Polyethyleneimine; D004247:DNA; C032802:hydroxypropyl methacrylate